GlaxoSmithKline Technical Analysis

<div class='circular--portrait' style='background:#754DEB;color: #F0FFF0;font-size:4em;padding-top: 25px;;'>GP</div>
GSK -- USA Stock  

Fiscal Quarter End: 30th of June 2020  

As of the 6th of June GlaxoSmithKline PLC retains Market Risk Adjusted Performance of 0.0919 and Risk Adjusted Performance of 0.0755. GlaxoSmithKline PLC technical analysis makes it possible for you to employ historical prices and volume momentum with intention to determine a pattern that calculates the direction of the corporation future prices. Simply put, you can use this information to find out if the corporation will indeed mirror its model of historical price patterns or the prices will eventually revert. We found nineteen technical drivers for GlaxoSmithKline PLC, which can be compared to its competitors. Please check out GlaxoSmithKline PLC Coefficient Of Variation as well as the relationship between Treynor Ratio and Semi Variance to decide if GlaxoSmithKline PLC is priced fairly providing market reflects its last-minute price of 41.7 per share. Given that GlaxoSmithKline PLC has Jensen Alpha of (0.007699), we strongly advise you confirm GlaxoSmithKline PLC regular market performance to make sure the company can sustain itself at future point.

Search Technical Analysis

 
Refresh
Target PriceAdvice# of Analysts
50.28Hold4Odds
GlaxoSmithKline PLC current and past analyst recommendations published by number of research institutions as well as average analyst consensus
GlaxoSmithKline PLC Analyst Advice  
GlaxoSmithKline PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of GlaxoSmithKline PLC technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst, therefore, looks at the history of GlaxoSmithKline PLC trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

GlaxoSmithKline PLC Technical Analysis

Indicator
Time Period
  Portfolio Suggestion    
  
Execute Indicator
 
The output start index for this execution was fifteen with a total number of output elements of fourty-six. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of GlaxoSmithKline PLC volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.

GlaxoSmithKline PLC Trend Analysis

Use this graph to draw trend lines for GlaxoSmithKline PLC. You can use it to identify possible trend reversals for GlaxoSmithKline PLC as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual GlaxoSmithKline PLC price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

GlaxoSmithKline PLC Best Fit Change Line

The following chart estimates an ordinary least squares regression model for GlaxoSmithKline PLC applied against its price change over selected period. The best fit line has a slop of   0.13  which may imply that GlaxoSmithKline PLC will maintain its good market sentiment and make money for investors. It has 122 observation points and a regression sum of squares at 623.28, which is the sum of squared deviations for the predicted GlaxoSmithKline PLC price change compared to its average price change.

About GlaxoSmithKline PLC Technical Analysis

The Macroaxis Technical Analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of GlaxoSmithKline PLC on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of GlaxoSmithKline PLC based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on GlaxoSmithKline PLC stock first instead of the macroeconomic environment surrounding GlaxoSmithKline PLC . By analyzing GlaxoSmithKline PLC's financials, daily price indicators, and its related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of GlaxoSmithKline PLC's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to GlaxoSmithKline PLC specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2017 2019 2020 (projected)
Long Term Debt to Equity4.652.072.7
Interest Coverage5.68146.89158.48
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GlaxoSmithKline PLC operates under Drug Manufacturers - General classification in USA and is traded on BATS Exchange. It employs 99437 people.

GlaxoSmithKline PLC June 6, 2020 Technical Indicators

GlaxoSmithKline PLC June 6, 2020 Daily Price Condition

Please check Risk vs Return Analysis. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page